[PHARMA] QoQ TTM Result on 30-Jun-2016 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Aug-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
30-Jun-2016 [#2]
Profit Trend
QoQ- -1.73%
YoY- -30.36%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Revenue 2,248,121 2,189,022 2,286,356 2,295,554 2,276,603 2,189,312 2,136,265 3.45%
PBT 73,256 72,017 91,665 97,079 100,648 112,722 126,859 -30.63%
Tax -26,609 -26,158 -28,865 -26,952 -29,520 -28,138 -21,695 14.56%
NP 46,647 45,859 62,800 70,127 71,128 84,584 105,164 -41.80%
-
NP to SH 46,143 45,599 62,497 69,407 70,629 84,044 104,679 -42.05%
-
Tax Rate 36.32% 36.32% 31.49% 27.76% 29.33% 24.96% 17.10% -
Total Cost 2,201,474 2,143,163 2,223,556 2,225,427 2,205,475 2,104,728 2,031,101 5.51%
-
Net Worth 544,360 531,169 531,250 524,177 515,906 529,786 534,373 1.24%
Dividend
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Div 41,456 41,442 51,803 64,750 69,935 77,704 90,625 -40.60%
Div Payout % 89.84% 90.88% 82.89% 93.29% 99.02% 92.46% 86.57% -
Equity
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Net Worth 544,360 531,169 531,250 524,177 515,906 529,786 534,373 1.24%
NOSH 259,219 259,377 259,146 258,981 258,859 259,064 259,027 0.04%
Ratio Analysis
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
NP Margin 2.07% 2.09% 2.75% 3.05% 3.12% 3.86% 4.92% -
ROE 8.48% 8.58% 11.76% 13.24% 13.69% 15.86% 19.59% -
Per Share
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
RPS 867.27 844.83 882.26 886.38 879.48 845.08 824.73 3.40%
EPS 17.80 17.60 24.12 26.80 27.28 32.44 40.41 -42.07%
DPS 16.00 16.00 20.00 25.00 27.00 30.00 35.00 -40.62%
NAPS 2.10 2.05 2.05 2.024 1.993 2.045 2.063 1.19%
Adjusted Per Share Value based on latest NOSH - 258,981
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
RPS 155.98 151.88 158.64 159.27 157.96 151.90 148.22 3.45%
EPS 3.20 3.16 4.34 4.82 4.90 5.83 7.26 -42.05%
DPS 2.88 2.88 3.59 4.49 4.85 5.39 6.29 -40.56%
NAPS 0.3777 0.3685 0.3686 0.3637 0.358 0.3676 0.3708 1.23%
Price Multiplier on Financial Quarter End Date
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Date 31/03/17 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 -
Price 4.89 5.30 5.58 5.50 5.76 6.36 6.50 -
P/RPS 0.56 0.63 0.63 0.62 0.65 0.75 0.79 -20.48%
P/EPS 27.47 30.12 23.14 20.52 21.11 19.60 16.08 42.85%
EY 3.64 3.32 4.32 4.87 4.74 5.10 6.22 -30.01%
DY 3.27 3.02 3.58 4.55 4.69 4.72 5.38 -28.22%
P/NAPS 2.33 2.59 2.72 2.72 2.89 3.11 3.15 -18.19%
Price Multiplier on Announcement Date
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Date 16/05/17 21/02/17 21/11/16 19/08/16 13/05/16 15/02/16 26/11/15 -
Price 4.72 5.05 5.70 5.62 5.60 6.19 6.50 -
P/RPS 0.54 0.60 0.65 0.63 0.64 0.73 0.79 -22.38%
P/EPS 26.52 28.70 23.64 20.97 20.52 19.08 16.08 39.54%
EY 3.77 3.48 4.23 4.77 4.87 5.24 6.22 -28.35%
DY 3.39 3.17 3.51 4.45 4.82 4.85 5.38 -26.48%
P/NAPS 2.25 2.46 2.78 2.78 2.81 3.03 3.15 -20.07%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment